Cladribine
FDA Approved: * February 28, 2000Pharm Company: * BEDFORD
Category: Cancer
Cladribine, sold under the brand name Leustatin, among others, is a medication used to treat hairy cell leukemia (leukemic reticuloendotheliosis) and B-cell chronic lymphocytic leukemia.[5][6] cladribine, sold under the brand name Mavenclad, is indicated for the treatment of adult patients with highly active forms of relapsing-remitting multiple sclerosis.[7] Cladribine (2-chloro-2'-deoxyadenosine [2-CdA]) is a purine analogue that selectively t... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.Dosage List
Cladribine 1 mg/ml Intravenous Injection
NDC: 0069-0086
Labeler:
Pfizer Laboratories Div Pfizer Inc.
Cladribine 1 mg/ml Intravenous Injection
NDC: 0069-0201
Labeler:
Pfizer Laboratories Div Pfizer Inc.
Cladribine 1 mg/ml Intravenous Injection, Solution
NDC: 42658-010
Labeler:
Hisun Pharmaceuticals USA, Inc.
